IMMUNE CHECKPOINT BLOCKADE (ICB) IN BRAIN METASTASES (BM) FROM ADVANCED SMALL CELL UROTHELIAL CANCER (ASCUC)

被引：0

作者：

Wilson, Nathaniel ^{[1
]}

Alhalabi, Omar ^{[2
]}

Hasanov, Elshad ^{[2
]}

Xiao, Lianchun ^{[2
]}

Papadopoulos, John ^{[2
]}

Campbell, Matthew ^{[2
]}

Shah, Amishi ^{[2
]}

Gao, Jianjun ^{[2
]}

Corn, Paul ^{[2
]}

Aparicio, Ana ^{[2
]}

Wang, Jennifer ^{[2
]}

Czerniak, Bogdan ^{[2
]}

Guo, Charles ^{[2
]}

Logothetis, Christopher ^{[2
]}

Li, Jing ^{[2
]}

Choi, Seungtaek ^{[2
]}

Tang, Chad ^{[2
]}

Tannir, Nizar ^{[2
]}

Siefker-Radtke, Arlene ^{[2
]}

机构：

[1] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷

关键词：

D O I：

10.1136/jitc-2021-SITC2021.241

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

241

引用

页码：A259 / A260

页数：2

共 50 条

[21] Mismatch repair (MMR) detection in urothelial carcinoma (UC) and correlation with immune checkpoint blockade (ICB) response.
Iyer, Gopa
Audenet, Francois
Middha, Sumit
Carlo, Maria Isabel
Regazzi, Ashley Marie
Funt, Samuel
Al-Ahmadie, Hikmat
Solit, David B.
Rosenberg, Jonathan E.
Bajorin, Dean F.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[22] The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases
Kitadai, Rui
Okuma, Yusuke
Hakozaki, Taiki
Hosomi, Yukio
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 777 - 785
[23] The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases
Rui Kitadai
Yusuke Okuma
Taiki Hakozaki
Yukio Hosomi
Journal of Cancer Research and Clinical Oncology, 2020, 146 : 777 - 785
[24] Immune checkpoint inhibitors for brain metastases in non-small-cell lung cancer: from rationale to clinical application
Xiao, Gang
Liu, Zhiyuan
Gao, Xuan
Wang, Han
Peng, Haiqin
Li, Jiahui
Yang, Lei
Duan, Hexin
Zhou, Rongrong
IMMUNOTHERAPY, 2021, 13 (12) : 1031 - 1051
[25] Impact of Brain Metastases in Immune Checkpoint Inhibitors (ICI) Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
Hendriks, L.
Henon, C.
Auclin, E.
Mezquita, L.
Ferrara, R.
Audigier-Valette, C.
Mazieres, J.
Lefebyre, C.
Le Moulec, S.
Cousin, S.
Duchemann, B.
Le Pechoux, C.
Botticella, A.
Ammari, S.
Gazzah, A.
Caramella, C.
Adam, J.
Planchard, D.
De Ruysscher, D.
Dingemans, A.
Besse, B.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S384 - S384
[26] Comparison of the efficacy and safety of anlotinib monotherapy or anlotinib plus immune checkpoint inhibitor for advanced small cell lung cancer with brain metastases
Xu, Manyi
Shao, Keda
Wang, Yanhua
Hao, Yue
Song, Zhengbo
CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (07): : 1687 - 1695
[27] Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
Nabet, Barzin
Hamidi, Habib
Lee, Myung Chang
Banchereau, Romain
Morris, Stefanie
Adler, Leah
Gayevskiy, Velimir
Elhossiny, Ahmed
Srivastava, Minu
Patil, Namrata
Smith, Kiandra
Jesudason, Rajiv
Chan, Caleb
Chang, Patrick
Fernandez, Matthew
Rost, Sandra
Mcginnis, Lisa
Koeppen, Hartmut
Gay, Carl
Minna, John
Heymach, John
Chan, Joseph
Rudin, Charles
Byers, Lauren
Liu, Stephen
Reck, Martin
Shames, David
CANCER CELL, 2024, 42 (03) : 429 - 443.e4
[28] Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with brain metastases
Yan, Xin
Qu, Fanjie
Zhou, Yi
LUNG CANCER, 2023, 184
[29] The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer
Ren, Sijia
Xiong, Xinxin
You, Hua
Shen, Jianfei
Zhou, Penghui
FRONTIERS IN IMMUNOLOGY, 2021, 12
[30] SMALL CELL LUNG CANCER MOLECULAR SUBTYPES AND VULNERABILITY TO IMMUNE CHECKPOINT BLOCKADE
Nabet, Barzin
Hamidi, Habib
Banchereau, Romain
Morris, Stefanie
Adler, Leah
Srivastava, Minu
Patil, Namrata
Gay, Carl
Minna, John
Heymach, John
Chan, Joseph
Rudin, Charles
Byers, Lauren
Liu, Stephen
Reck, Martin
Shames, David
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A549 - A549

← 1 2 3 4 5 →